Improving gastric balloons to treat obesity

Alexis Sudlow; Carel W le Roux

doi:10.1016/S0140-6736(21)02505-8

Improving gastric balloons to treat obesity

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	1940-1941
Number of pages	2
Journal	Lancet
Volume	398
Issue number	10315
Early online date	15 Nov 2021
DOIs	https://doi.org/10.1016/S0140-6736(21)02505-8
Publication status	Published (in print/issue) - 27 Nov 2021

Bibliographical note

Funding Information:
CWlR reports grants from the Irish Research Council, Science Foundation Ireland, Anabio, and the Health Research Board. He serves on advisory boards of Novo Nordisk, Herbalife, GI Dynamics, Eli Lilly, Johnson & Johnson, Sanofi Aventis, AstraZeneca, Janssen, Bristol-Myers Squibb, and Boehringer Ingelheim, outside the area of work commented on here. He also has been since January, 2011, the chief medical officer and director of the Medical Device Division, and is a previous investor in Keyron, which develops endoscopically implantable medical devices intended to mimic the surgical procedures of sleeve gastrectomy and gastric bypass. He divested stock holdings in Keyron in September, 2021. AS declares no competing interests.

Keywords

Body Weight
Gastric Balloon/adverse effects
Humans
Obesity/therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(21)02505-8

Cite this

@article{21ee442cc1e74ef1af3a0dfe9803b069,

title = "Improving gastric balloons to treat obesity",

keywords = "Body Weight, Gastric Balloon/adverse effects, Humans, Obesity/therapy",

author = "Alexis Sudlow and {le Roux}, {Carel W}",

note = "Funding Information: CWlR reports grants from the Irish Research Council, Science Foundation Ireland, Anabio, and the Health Research Board. He serves on advisory boards of Novo Nordisk, Herbalife, GI Dynamics, Eli Lilly, Johnson & Johnson, Sanofi Aventis, AstraZeneca, Janssen, Bristol-Myers Squibb, and Boehringer Ingelheim, outside the area of work commented on here. He also has been since January, 2011, the chief medical officer and director of the Medical Device Division, and is a previous investor in Keyron, which develops endoscopically implantable medical devices intended to mimic the surgical procedures of sleeve gastrectomy and gastric bypass. He divested stock holdings in Keyron in September, 2021. AS declares no competing interests.",

year = "2021",

month = nov,

day = "27",

doi = "10.1016/S0140-6736(21)02505-8",

language = "English",

volume = "398",

pages = "1940--1941",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "10315",

}

TY - JOUR

T1 - Improving gastric balloons to treat obesity

AU - Sudlow, Alexis

AU - le Roux, Carel W

N1 - Funding Information: CWlR reports grants from the Irish Research Council, Science Foundation Ireland, Anabio, and the Health Research Board. He serves on advisory boards of Novo Nordisk, Herbalife, GI Dynamics, Eli Lilly, Johnson & Johnson, Sanofi Aventis, AstraZeneca, Janssen, Bristol-Myers Squibb, and Boehringer Ingelheim, outside the area of work commented on here. He also has been since January, 2011, the chief medical officer and director of the Medical Device Division, and is a previous investor in Keyron, which develops endoscopically implantable medical devices intended to mimic the surgical procedures of sleeve gastrectomy and gastric bypass. He divested stock holdings in Keyron in September, 2021. AS declares no competing interests.

PY - 2021/11/27

Y1 - 2021/11/27

KW - Body Weight

KW - Gastric Balloon/adverse effects

KW - Humans

KW - Obesity/therapy

UR - http://www.scopus.com/inward/record.url?scp=85119909748&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(21)02505-8

DO - 10.1016/S0140-6736(21)02505-8

M3 - Comment/debate

C2 - 34793744

SN - 0140-6736

VL - 398

SP - 1940

EP - 1941

JO - Lancet

JF - Lancet

IS - 10315

ER -

Improving gastric balloons to treat obesity

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Cite this